Pooh R T,Ngan H,Lo C M,et al.Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence [J].Surg Oncol,2000,73:109-114.
[1]
Pooh R T,Ngan H,Lo C M,et al.Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence [J].Surg Oncol,2000,73:109-114.
[2]
Marelli L.Shusang V,Buscombe J R,et al.Transarterial injection of 131I-lipiedol, compared with chemoembolization,in the treatment of unresectable hepatacellular cancer [J].Nucl Med, 2009, 50:871-877.
[2]
Marelli L.Shusang V,Buscombe J R,et al.Transarterial injection of 131I-lipiedol, compared with chemoembolization,in the treatment of unresectable hepatacellular cancer [J].Nucl Med, 2009, 50:871-877.
[3]
Kim Q,Kim J H,Park I S,et al.Reappraisal of repeated transarterial ehemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion [J].Gastroenterol Hepatol, 2009, 24:806-814.
[3]
Kim Q,Kim J H,Park I S,et al.Reappraisal of repeated transarterial ehemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion [J].Gastroenterol Hepatol, 2009, 24:806-814.
[4]
Eisenhauer E A,11lem∞P,Bogaerts J,et al.New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1) [J].Gan To Kagaku Ryoho, 2009, 36(13): 2495-2501.
[4]
Eisenhauer E A,11lem∞P,Bogaerts J,et al.New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1) [J].Gan To Kagaku Ryoho, 2009, 36(13): 2495-2501.
2015, Vol. 26 
